The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors

Annals of Oncology

Volumn 25, Issue 5, 2014, Pages 1074-1075

  Cassier, P A ^a   Floquet, A ^b   Penel, N ^c   Derbel, O ^a   Bui N'guyen, B ^b   Guastalla, J P ^a   Pissaloux, D ^a   Treilleux, I ^a   Saba, C E ^d,e   Blay, J Y ^a,f   Ray Coquard, I ^a,f  

^a CENTRE LÉON BÉRARD   (France)

^b INSTITUT BERGONIÉ   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d NOVARTIS PHARMA K K   (Japan)

^e INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^f UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; INDOLE DERIVATIVE; PANOBINOSTAT;

ADULT; AGED; FEMALE; HUMAN; MIDDLE AGED; OVARIAN NEOPLASMS; PHASE 2 CLINICAL TRIAL (TOPIC); SEX CORD-GONADAL STROMAL TUMORS; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS, PHASE II AS TOPIC; FEMALE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; INDOLES; MIDDLE AGED; OVARIAN NEOPLASMS; SEX CORD-GONADAL STROMAL TUMORS; TREATMENT OUTCOME;

EID: 84921434855     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu045     Document Type: Letter

References (5)

1. Colombo, N., Parma, G., Zanagnolo, V., et al. Management of ovarian stromal cell tumors. J Clin Oncol 25 (2007), 2944–2951 doi:10.1200/JCO.2007.11.1005.
2. Homesley, H.D., Bundy, B.N., Hurteau, J.A., et al. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 72:2 (1999), 131–137 doi:10.1006/gyno.1998.5304.
3. Rubin, E.H., Agrawal, N.G., Friedman, E.J., et al. A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer. Clin Cancer Res 12:23 (2006), 7039–7045 doi:10.1158/1078-0432.CCR-06-1802.
4. Cassier, P.A., Lefranc, A., Amela, E.Y., et al. A phase II trial of panobinostat in patients with advanced pretreatedsoft tissue sarcoma. A study from the French Sarcoma Group. Br J Cancer 109:4 (2013), 909–914.
5. Mayr, D., Hirschmann, A., Marlow, S., et al. Analysis of selected oncogenes (AKT1, FOS, BCL2L2, TGFbeta) on chromosome 14 in granulosa cell tumors (GCTs): a comprehensive study on 30 GCTs combining comparative genomic hybridization (CGH) and fluorescence-in situ-hybridization (FISH). Pathol Res Pract 204:11 (2008), 823–830 doi:10.1016/j.prp.2008.07.009.